NRIX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $22.99

Capitalizzazione di Mercato (MRQ) $2.38B

P/E (TTM) -6.6

EPS (TTM) $-3.46

Ricavi (TTM) $37M

ROE (TTM) -80.3%

Intervallo 52 sett. $9–$28

NRIX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Nurix Therapeutics, Inc. - Common stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaBiotechnology dipendenti317 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$84M

2019-11-30 → 2025-11-30

EPS$-3.05

2021-11-30 → 2025-11-30

Flusso di cassa libero$-263M

2020-11-30 → 2025-11-30

Margine netto-928.4%

2020-11-30 → 2025-11-30

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	NRIX	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-6.6media 5 anni ≈-5.9	≈-5.9	·	·
P/S (TTM)	64.8media 5 anni ≈22.9	≈22.9	50.1	Valore equo
P/B (MRQ)	5.9media 5 anni ≈2.7	≈2.7	4.5	Valore equo
Price / FCF (Prezzo / FCF)	-8.9media 5 anni ≈-7.4	≈-7.4	·	·
Price / Cash Flow (Prezzo / Flusso di cassa)	-9.4media 5 anni ≈-7.9	≈-7.9	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	4.3media 5 anni ≈2.7	≈2.7	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	NRIX	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-982.4%media 5 anni ≈-360.9%	≈-360.9%	-7718.9%	Di prim'ordine
EBITDA Margin (Margine EBITDA)	-340.2%media 5 anni ≈-360.9%	≈-360.9%	-7701.1%	Di prim'ordine
Pretax Margin (Margine ante imposte)	-314.0%media 5 anni ≈-343.2%	≈-343.2%	-525.2%	Debole
Margine di Profitto Netto (TTM)	-928.4%media 5 anni ≈-343.5%	≈-343.5%	-7584.4%	Di prim'ordine
ROA (TTM)	-60.6%media 5 anni ≈-36.2%	≈-36.2%	-37.6%	Debole
ROE (TTM)	-80.3%media 5 anni ≈-50.2%	≈-50.2%	-43.8%	Debole
ROIC	-53.2%media 5 anni ≈-47.2%	≈-47.2%	-39.9%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	NRIX	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		6.3media 5 anni ≈5.2	≈5.2	14.6	Bassa liquidità
Quick Ratio		2.9media 5 anni ≈2.7	≈2.7	10.3	Bassa liquidità

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	NRIX	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	53.9%media 5 anni ≈44.2%	≈44.2%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	29.5%media 5 anni ≈38.3%	≈38.3%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	36.4%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	NRIX	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-3.05media 5 anni ≈$-3.00	≈$-3.00	·	·
Revenue / Share (Ricavi / Azione)	$0.97media 5 anni ≈$1.00	≈$1.00	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-2.88media 5 anni ≈$-2.56	≈$-2.56	·	·
Cash / Share (Liquidità / Azione)	$2.43media 5 anni ≈$1.63	≈$1.63	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	Tendenza 5 anni	NRIX	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)		0.1media 5 anni ≈0.1	≈0.1	0.1	Di prim'ordine
Revenue / Employee (Ricavi / Dipendente)		≈$264.9K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 3.0%

Prossimo report Ott 07, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Lug 7, 2026	$-0.81	$-0.73	-10.8%
31 Marzo 2026		$-0.79	$-0.77	-2.7%
31 Dicembre 2025		$-0.82	$-0.89	7.7%
30 Settembre 2025		$-1.03	$-0.86	-20.0%
30 Giugno 2025		$-0.52	$-0.74	30.1%
31 Marzo 2025		$-0.67	$-0.78	14.0%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 13

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue	$84M	$55M	$77M	$39M	$30M	$18M	$31M
R&D Expense	$317M	$222M	$189M	$184M	$116M	$66M	$45M
SG&A Expense	$53M	$46M	$43M	$38M	$31M	$16M	$8M
Operating Expenses	$370M	$268M	$232M	$222M	$148M	$83M	$53M
Operating Income	$-286M	$-213M	$-155M	$-184M	$-118M	$-65M	$-22M
Pretax Income	$-264M	$-193M	$-144M	$-180M	$-117M	$-64M	$-21M
Income Tax	$760.0K	$270.0K	$0	$0	$131.0K	$-21M	$239.0K
Net Income	$-264M	$-194M	$-144M	$-180M	$-117M	$-43M	$-22M
EPS (Basic)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·
EPS (Diluted)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·
Shares (Basic)	86,666,907	67,120,266	54,337,901	48,607,990	42,895,383	·	·
Shares (Diluted)	86,666,907	67,120,266	54,337,901	48,607,990	42,895,383	·	·
EBITDA	$-286M	$-213M	$-155M	$-184M	$-118M	$-65M	·

Stato Patrimoniale 21

Metrica	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$247M	$110M	$55M	$64M	$81M	$119M	$35M
Short-term Investments	·	·	·	$245M	$215M	$162M	$3M
Receivables	·	$0	·	$0	$6M	·	·
Prepaid Expense	$14M	$10M	$8M	$9M	$9M	$6M	$2M
Current Assets	$607M	$619M	$296M	$318M	$311M	$298M	$39M
PP&E (Net)	$22M	$18M	$17M	$17M	$11M	$7M	$4M
PP&E (Gross)	$60M	$52M	$43M	$37M	$26M	$20M	$15M
Accum. Depreciation	$38M	$35M	$26M	$20M	$15M	$13M	$11M
Other Non-current Assets	$7M	$3M	$4M	$4M	$3M	$177.0K	$147.0K
Total Assets	$688M	$669M	$356M	$417M	$477M	$396M	$44M
Accounts Payable	$11M	$11M	$6M	$5M	$7M	$3M	$2M
Current Liabilities	$86M	$96M	$87M	$71M	$66M	$45M	$16M
Capital Leases	$53M	$20M	$23M	$6M	$9M	·	·
Other Non-current Liabilities	·	·	·	·	·	$850.0K	$2M
Total Liabilities	$149M	$142M	$155M	$113M	$134M	$106M	$54M
Common Stock	$102.0K	$76.0K	$49.0K	$47.0K	$45.0K	$39.0K	$4.0K
Retained Earnings	$-1.00B	$-739M	$-545M	$-401M	$-221M	$-104M	$-60M
AOCI	$105.0K	$150.0K	$-655.0K	$-4M	$-608.0K	$87.0K	$-2.0K
Stockholders' Equity	$539M	$527M	$200M	$304M	$342M	$290M	$-58M
Liabilities + Equity	$688M	$669M	$356M	$417M	$477M	$396M	$44M
Shares Outstanding	101,807,484	75,870,718	48,718,552	47,172,299	44,664,371	38,864,872	3,595,334

Flusso di cassa 11

Metrica	2025	2024	2023	2022	2021	2020	2019
D&A	$9M	$9M	$8M	$5M	$3M	$2M	$2M
Stock-based Comp	$38M	$34M	$34M	$28M	$16M	$4M	$510.0K
Operating Cash Flow	$-249M	$-173M	$-81M	$-160M	$-84M	$-80.0K	$601.0K
CapEx	$14M	$9M	$8M	$12M	$6M	$5M	$2M
Investing Cash Flow	$148M	$-258M	$68M	$27M	$-108M	$-254M	$8M
Stock Issued	$0	$290M	$0	$19M	$150M	$218M	·
Net Stock Activity	$0	$290M	$0	$19M	$150M	$218M	·
Financing Cash Flow	$239M	$486M	$3M	$117M	$154M	$339M	$126.0K
Net Change in Cash	$137M	$55M	$-10M	$-15M	$-39M	$85M	$9M
Taxes Paid	·	·	·	·	·	$1.0K	$1.0K
Free Cash Flow	$-263M	$-182M	$-90M	$-172M	$-90M	$-5M	·

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%	-364.7%	·
Net Margin	-314.9%	-354.9%	-187.0%	-466.9%	-393.9%	-242.7%	·
Pretax Margin	-314.0%	-354.4%	-187.0%	-466.9%	-393.5%	-357.9%	·
EBITDA Margin	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%	-364.7%	·
ROA	-39.0%	-37.8%	-37.3%	-40.4%	-26.9%	-19.6%	·
ROE	-53.6%	-42.8%	-66.3%	-55.8%	-32.7%	-14.5%	·
ROIC	-53.2%	-40.5%	·	-60.5%	-34.5%	-15.2%	·

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019
Current Ratio		7.0	6.5	3.4	4.5	4.7	6.7	·
Quick Ratio		2.9	1.1	0.6	4.4	4.6	6.3	·

Efficienza 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.1	0.1	0.2	0.1	0.1	0.1	·
Receivables Turnover		·	·	·	12.9	9.9	·	·

Per Azione 6

Metrica	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$5.29	$6.95	$4.12	$6.44	$7.66	$7.47	·
Revenue / Share	$0.97	$0.81	$1.42	$0.79	·	·	·
Cash Flow / Share	$-2.88	$-2.57	$-1.50	$-3.29	·	·	·
Cash / Share	$2.43	$1.45	$1.12	$1.37	$1.80	$3.07	·
Dividend / Share	$0.00	$0.00	·	·	·	$0.00	$0.00
EPS (TTM)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	53.9%	-29.1%	99.3%	29.8%	67.0%	·	·
Revenue CAGR 3Y	29.5%	22.4%	62.9%	·	·	·	·
Revenue CAGR 5Y	36.4%	·	·	·	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$84M	$55M	$77M	$39M	$30M	$18M	·
Net Income TTM	$-264M	$-194M	$-144M	$-180M	$-117M	$-43M	·
Market Cap	$1.80B	$1.68B	$303M	$584M	$1.29B	$1.66B	·
P/E	-5.8	-7.7	-2.3	-3.3	-10.6	·	·
P/S	21.4	30.8	3.9	15.1	43.3	93.0	·
P/B	3.3	3.2	1.5	1.9	3.8	5.7	·
P / Tangible Book	3.3	3.2	1.5	1.9	3.8	5.7	·
P / Cash Flow	-7.2	-9.7	-3.7	-3.7	-15.3	-20705.3	·
P / FCF	-6.8	-9.2	-3.4	-3.4	-14.3	-357.5	·
Earnings Yield	-17.2%	-13.0%	-42.6%	-29.9%	-9.5%	·	·

Conto Economico 13

Metrica	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$9M	$6M	$14M	$8M	$44M	$18M	$13M	$13M	$12M	$17M	$15M	$18M	$31M	$13M	$7M	$11M
R&D Expense	$88M	$84M	$83M	$86M	$78M	$70M	$67M	$55M	$49M	$50M	$50M	$48M	$46M	$46M	$46M	$48M
SG&A Expense	$16M	$15M	$14M	$13M	$14M	$12M	$11M	$12M	$12M	$12M	$11M	$11M	$12M	$10M	$9M	$10M
Operating Expenses	$103M	$99M	$97M	$99M	$92M	$81M	$78M	$67M	$61M	$62M	$60M	$58M	$57M	$56M	$55M	$58M
Operating Income	$-94M	$-92M	$-83M	$-91M	$-48M	$-63M	$-65M	$-55M	$-49M	$-45M	$-45M	$-40M	$-27M	$-43M	$-49M	$-47M
Pretax Income	$-90M	·	$-78M	$-86M	$-43M	$-56M	$-59M	$-49M	$-44M	$-41M	$-42M	$-37M	$-24M	$-41M	$-47M	$-46M
Income Tax	$-271.0K	$0	$0	$0	$760.0K	$0	$8.0K	$82.0K	$90.0K	$90.0K	$0	$0	$0	$0	$0	$0
Net Income	$-90M	$-87M	$-78M	$-86M	$-43M	$-56M	$-59M	$-49M	$-45M	$-42M	$-42M	$-37M	$-24M	$-41M	$-47M	$-46M
EPS (Basic)	$-0.81	$-0.79	$-0.83	$-1.03	$-0.52	$-0.67	$-0.74	$-0.67	$-0.71	$-0.76	$-0.77	$-0.68	$-0.45	$-0.75	$-0.85	$-0.90
EPS (Diluted)	$-0.81	$-0.79	$-0.83	$-1.03	$-0.52	$-0.67	$-0.74	$-0.67	$-0.71	$-0.76	$-0.77	$-0.68	$-0.45	$-0.75	$-0.85	$-0.90
Shares (Basic)	111,084,423	110,071,668	·	84,159,336	83,882,477	83,560,795	·	72,779,381	62,377,551	54,903,407	·	54,390,859	54,259,045	54,028,238	·	50,868,542
Shares (Diluted)	111,084,423	110,071,668	·	84,159,336	83,882,477	83,560,795	·	72,779,381	62,377,551	54,903,407	·	54,390,859	54,259,045	54,028,238	·	50,868,542
EBITDA	$-94M	$-92M	·	$-91M	$-48M	$-63M	·	$-55M	$-49M	$-45M	·	$-40M	$-27M	$-43M	·	$-47M

Stato Patrimoniale 20

Metrica	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$68M	$71M	$247M	$78M	$84M	$76M	$110M	$99M	$117M	$50M	$55M	$42M	$59M	$34M	$64M	$48M
Short-term Investments	·	·	·	·	·	·	·	·	·	·	·	$217M	$222M	$244M	·	$297M
Receivables	·	·	·	·	$19M	·	·	·	·	·	·	$2M	·	·	·	·
Prepaid Expense	$13M	$14M	$14M	$12M	$11M	$14M	$10M	$8M	$7M	$7M	·	$7M	$9M	$11M	·	$10M
Current Assets	$456M	$554M	$607M	$441M	$515M	$564M	$619M	$456M	$450M	$251M	·	$268M	$290M	$288M	·	$355M
PP&E (Net)	$20M	$22M	$22M	$20M	$19M	$18M	$18M	$17M	$19M	$18M	·	$17M	$18M	$18M	·	$17M
PP&E (Gross)	$61M	$61M	$60M	$61M	$57M	$55M	$52M	$49M	$48M	$46M	·	$42M	$42M	$39M	·	$35M
Accum. Depreciation	$41M	$40M	$38M	$41M	$39M	$37M	$35M	$32M	$30M	$28M	·	$25M	$23M	$21M	·	$18M
Other Non-current Assets	$8M	$7M	$7M	$7M	$6M	$6M	$3M	$3M	$3M	$3M	·	$4M	$4M	$4M	·	$4M
Total Assets	$536M	$636M	$688M	$522M	$592M	$615M	$669M	$514M	$511M	$313M	·	$308M	$351M	$370M	·	$459M
Accounts Payable	$12M	$10M	$11M	$9M	$6M	$8M	$11M	$4M	$3M	$6M	·	$2M	$5M	$6M	·	$6M
Current Liabilities	$72M	$92M	$86M	$82M	$76M	$90M	$96M	$86M	$81M	$88M	·	$61M	$72M	$65M	·	$68M
Capital Leases	$55M	$55M	$53M	$53M	$47M	$20M	$20M	$21M	$21M	$22M	·	$3M	$4M	$5M	·	$8M
Total Liabilities	$133M	$155M	$149M	$150M	$144M	$134M	$142M	$137M	$140M	$144M	·	$74M	$91M	$96M	·	$117M
Common Stock	$104.0K	$103.0K	$102.0K	$77.0K	$76.0K	$76.0K	$76.0K	$67.0K	$64.0K	$49.0K	·	$49.0K	$48.0K	$47.0K	·	$47.0K
Retained Earnings	$-1.18B	$-1.09B	$-1.00B	$-925M	$-839M	$-795M	$-739M	$-680M	$-631M	$-587M	·	$-503M	$-466M	$-442M	·	$-355M
AOCI	$-145.0K	$56.0K	$105.0K	$119.0K	$-20.0K	$226.0K	$150.0K	$344.0K	$-135.0K	$-350.0K	·	$-1M	$-2M	$-3M	·	$-4M
Stockholders' Equity	$403M	$481M	$539M	$372M	$448M	$481M	$527M	$377M	$371M	$169M	$200M	$234M	$260M	$274M	$304M	$343M
Liabilities + Equity	$536M	$636M	$688M	$522M	$592M	$615M	$669M	$514M	$511M	$313M	·	$308M	$351M	$370M	·	$459M
Shares Outstanding	103,701,511	103,399,813	101,807,484	76,872,686	76,433,664	76,234,799	75,870,718	67,083,523	64,356,535	49,136,954	·	48,503,768	47,631,208	47,444,853	·	47,147,781

Flusso di cassa 10

Metrica	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	·	$2M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Stock-based Comp	·	$9M	$9M	$10M	$10M	$9M	$9M	$9M	$9M	$8M	$8M	$8M	$9M	$8M	$8M	$7M
Operating Cash Flow	·	$-72M	$-68M	$-57M	$-63M	$-61M	$-49M	$-42M	$-40M	$-42M	$27M	$-41M	$-18M	$-48M	$-38M	$-46M
CapEx	·	$1M	$5M	$3M	$3M	$3M	$2M	$2M	$2M	$3M	$3M	$2M	$1M	$2M	$3M	$3M
Investing Cash Flow	·	$-124M	$346.0K	$50M	$71M	$26M	$-141M	$-21M	$-131M	$36M	$-14M	$23M	$44M	$16M	$55M	$-63M
Stock Issued	·	$18M	$0	$0	·	$0	$199M	$42M	·	·	$0	$0	·	·	$0	·
Net Stock Activity	·	$18M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	·	$20M	$236M	$1M	$6.0K	$1M	$201M	$46M	$238M	$2M	$7.0K	$2M	$25.0K	$1M	$-135.0K	$115M
Net Change in Cash	·	$-176M	$169M	$-6M	$8M	$-34M	$11M	$-18M	$67M	$-5M	$12M	$-17M	$25M	$-31M	$17M	$6M
Free Cash Flow	·	$-73M	·	·	·	$-65M	·	·	·	$-45M	·	·	·	$-51M	·	·

Redditività 7

Metrica	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1041.7%	-1479.4%	·	-1157.6%	-109.7%	-340.7%	·	-433.8%	-401.4%	-272.7%	·	-216.7%	-87.2%	-338.6%	·	-432.9%
Net Margin	-990.1%	-1394.3%	·	-1094.8%	-98.7%	-305.4%	·	-388.9%	-368.4%	-250.3%	·	-200.3%	-79.1%	-321.1%	·	-423.6%
Pretax Margin	-993.1%	·	·	-1094.8%	-96.9%	-305.4%	·	-388.3%	-367.6%	-249.8%	·	·	·	·	·	-423.6%
EBITDA Margin	-1041.7%	-1479.4%	·	-1157.6%	-109.7%	-340.7%	·	-433.8%	-401.4%	-272.7%	·	-216.7%	-87.2%	-338.6%	·	-432.9%
ROA	-15.9%	·	·	-16.7%	-7.9%	-12.2%	·	-11.9%	-10.3%	-12.2%	·	-9.6%	-6.5%	-10.1%	·	-9.6%
ROE	-21.1%	·	·	-23.1%	-10.6%	-17.3%	·	-16.0%	-14.1%	-18.8%	·	-12.8%	-9.2%	-14.1%	·	-12.7%
ROIC	-23.3%	·	·	-24.6%	-11.0%	-13.1%	·	-14.5%	-13.1%	-26.9%	·	·	·	·	·	-13.6%

Liquidità e Solvibilità 2

Metrica	Tendenza	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		6.3	·	·	5.4	6.8	6.3	·	5.3	5.6	2.9	·	4.4	4.0	4.4	·	5.3
Quick Ratio		0.9	·	·	1.0	1.4	0.8	·	1.1	1.4	0.6	·	4.2	3.9	4.3	·	5.1

Efficienza 2

Metrica	Tendenza	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	·	·	0.0	0.1	0.0	·	0.0	0.0	0.0	·	0.0	0.1	0.0	·	0.0
Receivables Turnover		·	·	·	·	4.1	·	·	·	·	·	·	18.5	·	·	·	·

Per Azione 6

Metrica	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$3.88	·	·	$4.84	$5.86	$6.31	·	$5.62	$5.76	$3.43	·	$4.82	$5.46	$5.78	·	$7.27
Revenue / Share	$0.08	$0.06	·	$0.09	$0.53	$0.22	·	$0.17	$0.19	$0.30	·	$0.34	$0.57	$0.23	·	$0.21
Cash Flow / Share	·	$-0.65	·	·	·	$-0.73	·	·	·	$-0.76	·	·	·	$-0.90	·	·
Cash / Share	$0.65	·	·	$1.02	$1.10	$1.00	·	$1.48	$1.81	$1.01	·	$0.87	$1.24	$0.71	·	$1.01
Dividend / Share	·	$0.00	$0.00	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00
EPS (TTM)	$-3.46	$-3.17	·	·	·	·	·	$-2.91	$-2.92	$-2.66	·	$-2.73	$-2.95	$-3.51	·	$-3.71

Valutazione (TTM) 9

Metrica	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$37M	$77M	·	·	·	·	·	$56M	$62M	$81M	·	$69M	$61M	$42M	·	$39M
Net Income TTM	·	$-273M	·	·	·	·	·	$-177M	$-165M	$-145M	·	$-149M	$-157M	$-179M	·	$-171M
Market Cap	$1.84B	·	·	$718M	$812M	$1.18B	·	$1.69B	$1.01B	$607M	·	$412M	$482M	$447M	·	$742M
P/E	-5.1	-5.3	·	·	·	·	·	-8.7	-5.4	-4.6	·	-3.1	-3.4	-2.7	·	-4.2
P/S	50.1	·	·	·	·	·	·	30.0	16.3	7.5	·	6.0	7.9	10.7	·	18.9
P/B	4.6	·	·	1.9	1.8	2.4	·	4.5	2.7	3.6	·	1.8	1.9	1.6	·	2.2
P / Tangible Book	4.6	·	·	1.9	1.8	2.4	·	4.5	2.7	3.6	·	1.8	1.9	1.6	·	2.2
P / Cash Flow	·	·	·	·	·	-19.3	·	·	·	-14.5	·	·	·	-9.2	·	·
Earnings Yield	-19.5%	-18.9%	·	·	·	·	·	-11.6%	-18.5%	-21.5%	·	-32.1%	-29.1%	-37.2%	·	-23.6%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Ricavi	$84M	$55M	$77M	$39M	$30M
Margine Operativo %	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%
Utile netto	$-264M	$-194M	$-144M	$-180M	$-117M
EPS Diluito	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73

Metrica	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Rapporto corrente	7.0	6.5	3.4	4.5	4.7
Quick Ratio	2.9	1.1	0.6	4.4	4.6

Metrica	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Flusso di cassa libero	$-263M	$-182M	$-90M	$-172M	$-90M

Proprietari istituzionali (13F) 223 filer · $2.8B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 223

Valore detenuto $2.8B

Nuove posizioni 47

Posizioni chiuse 26

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
47 (+3 vs trimestre precedente)	26 (0 vs trimestre precedente)	67 (-2 vs trimestre precedente)	63 (+20 vs trimestre precedente)	-283K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
BlackRock, Inc.	$212.768.666	8.770.349	7,57%	Azioni
Vestal Point Capital, LP	$195.293.000	8.050.000	6,95%	Azioni
Deep Track Capital, LP	$187.686.398	7.736.455	6,68%	Azioni
Rubric Capital Management LP	$175.345.894	7.227.778	6,24%	Azioni
FMR LLC	$133.071.325	5.485.215	4,73%	Azioni
MORGAN STANLEY	$115.537.879	4.762.484	4,11%	Azioni
STATE STREET CORP	$113.469.939	4.677.244	4,04%	Azioni
BAKER BROS. ADVISORS LP	$113.016.569	4.658.556	4,02%	Azioni
VANGUARD GROUP INC	$112.862.243	5.949.512	4,01%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$109.061.534	4.495.529	3,88%	Azioni
PERCEPTIVE ADVISORS LLC	$104.813.438	4.320.422	3,73%	Azioni
Redmile Group, LLC	$98.830.073	4.073.787	3,51%	Azioni
GENERAL ATLANTIC, L.P.	$73.560.808	3.032.185	2,62%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$61.566.526	2.537.291	2,19%	Azioni
Pictet Asset Management Holding SA	$57.040.888	2.351.232	2,03%	Azioni
ARK Investment Management LLC	$43.502.930	1.793.196	1,55%	Azioni
Capital World Investors	$43.374.842	1.787.916	1,54%	Azioni
Trails Edge Capital Partners, LP	$38.166.318	1.573.220	1,36%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$35.974.208	1.482.861	1,28%	Azioni
CITADEL ADVISORS LLC	$35.832.481	1.477.019	1,27%	Azioni
Soleus Capital Management, L.P.	$35.544.854	1.465.163	1,26%	Azioni
DIMENSIONAL FUND ADVISORS LP	$34.720.069	1.431.317	1,23%	Azioni
EVENTIDE ASSET MANAGEMENT, LLC	$31.486.884	1.297.893	1,12%	Azioni
BRAIDWELL LP	$31.217.016	1.286.769	1,11%	Azioni
Kynam Capital Management, LP	$28.984.805	1.194.757	1,03%	Azioni
Woodline Partners LP	$25.812.786	1.064.006	0,92%	Azioni
Sumitomo Mitsui Trust Group, Inc.	$23.858.788	983.462	0,85%	Azioni
Amova Asset Management Americas, Inc.	$23.848.954	983.462	0,85%	Azioni
Affinity Asset Advisors, LLC	$23.474.461	967.620	0,83%	Azioni
UBS Group AG	$22.249.259	917.117	0,79%	Azioni
NORTHERN TRUST CORP	$21.253.458	876.070	0,76%	Azioni
BANK OF AMERICA CORP /DE/	$20.429.079	842.089	0,73%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$20.215.761	833.296	0,72%	Azioni
Nuveen, LLC	$20.034.709	825.833	0,71%	Azioni
GOLDMAN SACHS GROUP INC	$19.737.670	813.589	0,70%	Azioni
KENNEDY CAPITAL MANAGEMENT LLC	$17.576.564	724.508	0,63%	Azioni
VANGUARD FIDUCIARY TRUST CO	$16.650.560	686.338	0,59%	Azioni
Rhenman & Partners Asset Management AB	$16.599.905	684.250	0,59%	Azioni
RAYMOND JAMES FINANCIAL INC	$14.392.512	593.262	0,51%	Azioni
Sofinnova Investments, Inc.	$12.714.617	524.098	0,45%	Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$11.575.441	477.141	0,41%	Azioni
Elmind Capital, LP	$11.159.600	460.000	0,40%	Azioni
CITIGROUP INC	$9.446.456	389.384	0,34%	Azioni
Candriam S.C.A.	$9.159.082	377.902	0,33%	Azioni
Fisher Asset Management, LLC	$8.963.219	369.465	0,32%	Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC	$8.821.009	363.603	0,31%	Azioni
FIRST TRUST ADVISORS LP	$8.754.172	360.848	0,31%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$8.262.422	340.578	0,29%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$8.106.188	334.138	0,29%	Azioni
ArrowMark Colorado Holdings LLC	$7.636.126	314.762	0,27%	Azioni

Mostra tutti i 223 proprietari istituzionali →

Insider aziendali 20 insider · 6 dirigenti · 11 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Arthur T Sands	President, CEO	10 Febbraio 2026 A	·	0	$0
Hans Van Houte	Chief Financial Officer	04 Agosto 2026 S	40.166	10	$-635.401
Stefani Wolff	EVP and COO	30 Aprile 2023 M	6.113	0	$0
Christine Ring	Chief Legal Officer	02 Ottobre 2026 M	9.110	21	$-3.398.693
Gwenn Hansen	Chief Scientific Officer	01 Settembre 2026 M	117.227	10	$-630.908
Pierre Beaurang	Chief Business Officer	10 Agosto 2021 M	4.330	0	$0
Edward C Saltzman	Direttore	15 Maggio 2026 A	·	0	$0
Roger D Dansey	Direttore	15 Maggio 2026 A	·	0	$0
David L. Lacey	Direttore	15 Maggio 2026 A	·	0	$0
Anil Kapur	Direttore	15 Maggio 2026 A	·	0	$0
Roy D. Baynes	Direttore	15 Maggio 2026 A	·	0	$0
Paul M Silva	Direttore	15 Maggio 2026 A	·	0	$0
Lori Anne Kunkel	Direttore	19 Maggio 2025 A	0	0	$0
Clay B Siegall	Direttore	05 Maggio 2022 A	·	0	$0
Jeffrey K Tong	Direttore	06 Maggio 2021 A	·	0	$0
Robert Tjian	Direttore	28 Luglio 2020 C	124.999	0	$0
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.	Proprietario del 10%	28 Luglio 2020 C	784.313	0	$0
Judith A Reinsdorf	·	15 Maggio 2026 A	·	0	$0
Julia P Gregory	·	15 Maggio 2026 A	10.750	0	$0
Leon Chen	·	06 Maggio 2021 A	·	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 41 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
ARKG · ARK ETF Trust	2,51%	1.682.054 NS	31 Luglio 2026	N-PORT
PTH · Invesco Exchange-Traded Fund Trust	1,24%	153.433 SH	02 Ottobre 2026	Giornaliero
BBC · ETFis Series Trust I	0,92%	18.337 NS	31 Luglio 2026	N-PORT
IWC · iShares Trust	0,59%	325.791 SH	11 Settembre 2026	Giornaliero
LABU · Direxion Shares ETF Trust	0,39%	83.566 NS	31 Luglio 2026	N-PORT
FYC · First Trust Exchange-Traded AlphaDE…	0,38%	212.938 NS	31 Luglio 2026	N-PORT
DWAS · Invesco Exchange-Traded Fund Trust …	0,36%	62.236 SH	02 Ottobre 2026	Giornaliero
IBB · iShares Trust	0,19%	749.550 SH	11 Settembre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,16%	7.333 SH	02 Ottobre 2026	Giornaliero
IWO · iShares Trust	0,13%	693.157 SH	11 Settembre 2026	Giornaliero
FYX · First Trust Exchange-Traded AlphaDE…	0,12%	71.916 NS	31 Luglio 2026	N-PORT
FFSM · FIDELITY COVINGTON TRUST	0,11%	71.221 NS	31 Luglio 2026	N-PORT
PWS · Pacer Funds Trust	0,11%	1.142 NS	31 Luglio 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0,11%	79.174 SH	19 Agosto 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,09%	103.798 SH	02 Ottobre 2026	Giornaliero
IWM · iShares Trust	0,08%	2.461.076 SH	11 Settembre 2026	Giornaliero
FAD · First Trust Exchange-Traded AlphaDE…	0,08%	19.290 NS	31 Luglio 2026	N-PORT
RSSL · Global X Funds	0,07%	45.904 NS	31 Luglio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,07%	551.605 SH	19 Agosto 2026	Giornaliero
OMFS · Invesco Exchange-Traded Self-Indexe…	0,06%	6.461 SH	02 Ottobre 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,05%	313.021 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,03%	1.114.166 SH	19 Agosto 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,03%	19.327 SH	19 Agosto 2026	Giornaliero
ISCG · iShares Trust	0,03%	9.673 SH	11 Settembre 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,02%	29.479 NS	31 Luglio 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,02%	186.845 SH	19 Agosto 2026	Giornaliero
WSML · iShares Trust	0,02%	4.261 SH	11 Settembre 2026	Giornaliero
TILT · FlexShares Trust	0,01%	8.908 NS	31 Luglio 2026	N-PORT
DFAC · Dimensional ETF Trust	0,01%	181.202 NS	31 Luglio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,01%	7.762 NS	31 Luglio 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	21.135 NS	31 Luglio 2026	N-PORT
ITOT · iShares Trust	0,00%	136.268 SH	11 Settembre 2026	Giornaliero
IWV · iShares Trust	0,00%	27.695 SH	11 Settembre 2026	Giornaliero
DFSU · Dimensional ETF Trust	0,00%	3.425 NS	31 Luglio 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	16.122 NS	31 Luglio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	3.275.161 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	7.909 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	210.645 SH	11 Settembre 2026	Giornaliero
ISCB · iShares Trust	·	3.438 SH	11 Settembre 2026	Giornaliero
ISCV · iShares Trust	·	10.240 SH	11 Settembre 2026	Giornaliero
SMLF · iShares Trust	·	88.041 SH	11 Settembre 2026	Giornaliero

NRIX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 21 analisti COMPRA

Target mediano $34.00 +47,9%

7 33,3% Acquisto forte

12 57,1% Compra

2 9,5% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

14 analisti · 2026-09-29

Target medio $33.93 +47,6%

← Sotto tutti i target Prezzo attuale $22.99

Basso$25.00 Media$33.93 Alto$45.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
NRIX	$1.80B	-5.8	53.9%	-314.9%	-53.6%	·
PURR	$1.58B	2.5	·	3229.8%	24.8%	·
BEAM	$2.82B	-34.2	120.0%	-57.2%	-7.0%	·
IRON	$3.01B	-13.2	·	·	-31.3%	·
CLDX	$1.81B	-7.0	-78.0%	-16748.0%	-43.8%	·
IMNM	$2.43B	-8.8	-23.2%	-3060.0%	-47.0%	·
SLS	$577M	-15.1	·	·	-55.4%	·
VRDN	$3.17B	-7.7	23359.9%	-483.6%	-55.4%	·
RXRX	$2.16B	-2.8	26.9%	-863.4%	-62.9%	·

Ultime notizie Notizie recenti che menzionano questa società

23

Roche And Nurix Ink $2.3 Bln Collaboration To Co-Develop BTK Degrader Bexobrutideg Nasdaq · 3 mesi, 3 settimane fa Nurix Therapeutics Registra una Perdita Maggiore nel Q1 Nasdaq · 5 mesi, 3 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

NRIX Nurix Therapeutics, Inc. - Common stock